Cystic Fibrosis Screening and Testing During Pregnancy

Cystic fibrosis (CF) is a genetic disorder that affects the body’s ability to regulate salt and water movement in and out of cells. This causes thick, sticky mucus to build up in the lungs, digestive system, and other organs, leading to breathing difficulties, infections, and digestive issues. CF is caused by mutations in the CFTR gene, which is responsible for maintaining the balance of salt and fluids in the body.

In the UK, cystic fibrosis is one of the most common life-threatening genetic conditions. Symptoms typically begin in early childhood and worsen over time, though treatments have improved significantly in recent decades, extending the life expectancy and quality of life for those living with CF. However, there is still no cure, and management involves regular treatments to control symptoms and prevent complications.

Cystic fibrosis is caused by mutations in the CFTR gene. This gene is responsible for producing a protein that regulates the movement of salt and water in and out of the cells. In people with cystic fibrosis, the faulty gene causes the body to produce thick and sticky mucus, primarily affecting the lungs and digestive system. These gene mutations must be inherited from both parents for a person to develop CF.

The most common mutation responsible for cystic fibrosis is known as ΔF508. If both parents carry a faulty CFTR gene, they have a 1 in 4 chance of passing on the condition to their child. Even if both parents are carriers, they may not show any symptoms themselves, which is why genetic screening is often recommended for those planning a family.

Cystic fibrosis can be diagnosed through newborn screening, which is routinely offered to all babies in the UK. The test involves taking a small blood sample to check for the presence of the faulty CFTR gene and other related indicators. If the screening suggests CF, further tests like a sweat test or genetic testing are carried out to confirm the diagnosis.

In addition to newborn screening, prenatal testing methods like amniocentesis or chorionic villus sampling (CVS) can also diagnose cystic fibrosis before birth. These tests check for the CFTR gene mutation in the unborn baby, providing families with important information about potential care needs after birth.

Cystic fibrosis primarily affects the lungs and digestive system, leading to a wide range of symptoms. The most common symptoms include persistent coughing, frequent lung infections, and shortness of breath due to the build-up of thick mucus in the airways. Over time, lung function can decline, making breathing increasingly difficult and leading to chronic respiratory issues.

CF also affects the digestive system by blocking the pancreas, making it harder to digest food and absorb nutrients. This can cause poor growth, malnutrition, and fatty stools. Other symptoms may include salty-tasting skin, clubbing of the fingers and toes, and in men, infertility due to blockages in the reproductive tract.

Cystic fibrosis is inherited in an autosomal recessive manner (this means a child only develops it if they inherit a faulty gene from both parents), meaning that a child must inherit two faulty copies of the CFTR gene (one from each parent) to develop the condition. If both parents carry one faulty gene, there is a 25% chance with each pregnancy that their child will have cystic fibrosis, a 50% chance that the child will be a carrier, and a 25% chance that the child will inherit two normal genes.

Being a carrier means having one normal CFTR gene and one faulty gene. Carriers typically do not show any symptoms of cystic fibrosis but can pass the gene mutation on to their children. In the UK, about 1 in 25 people are CF carriers.

Cystic fibrosis treatments focus on managing symptoms and slowing disease progression, as there is currently no cure. Airway clearance techniques such as chest physiotherapy help loosen mucus in the lungs, making it easier to cough up. Inhaled medications, such as bronchodilators and mucus-thinning agents, are also commonly prescribed to improve lung function and reduce inflammation.

Advances in medication, including CFTR modulators, have revolutionised CF care by targeting the underlying genetic defect. Additionally, antibiotics are used to treat lung infections, and enzyme supplements help with digestion and nutrient absorption. Maintaining a high-calorie, nutrient-dense diet is also essential for people with CF to support their energy needs.

Currently, there is no cure for cystic fibrosis, but significant advancements in treatment have greatly improved the outlook for people living with the condition. Research is ongoing, with gene therapy and new medications aiming to address the root cause of the disease. CFTR modulators, for example, help some people with specific mutations by improving the function of the faulty protein.

Despite the lack of a cure, early diagnosis and comprehensive treatment can help manage symptoms, reduce complications, and extend life expectancy. In recent years, the median life expectancy for people with CF in the UK has increased to over 50 years.

Cystic fibrosis affects the lungs by causing the buildup of thick, sticky mucus that can block airways and trap bacteria. This makes people with CF more prone to lung infections, such as pneumonia and bronchitis, which can lead to frequent hospitalisations. Over time, these infections cause inflammation and damage to lung tissue, resulting in progressive loss of lung function.

People with CF often experience symptoms like chronic coughing, wheezing, and shortness of breath. Daily airway clearance techniques, along with medications to thin mucus and fight infections, are crucial for maintaining lung health and preventing complications like bronchiectasis.

Cystic fibrosis affects the digestive system by blocking the release of digestive enzymes from the pancreas, making it difficult for the body to break down food and absorb nutrients. This can lead to malnutrition, poor growth, and difficulty gaining weight. Many people with CF need to take pancreatic enzyme supplements with meals to aid digestion.

CF can also cause other digestive issues, including constipation, abdominal pain, and fatty stools (steatorrhea). Maintaining a high-calorie diet rich in fats and protein is essential to meet the increased energy needs of people with cystic fibrosis.

Thanks to advances in treatments, the life expectancy for people with cystic fibrosis has significantly improved. In the UK, the median life expectancy for those with CF is now over 50 years. Many people with CF can live full, active lives into middle age, though the severity of symptoms can vary between individuals.

Early diagnosis, comprehensive care, and the use of CFTR modulators and other treatments have played a significant role in extending life expectancy. Regular monitoring and proactive management of complications, especially lung infections, are key to improving outcomes for people with cystic fibrosis.

Yes, cystic fibrosis can be detected before birth through prenatal testing. If both parents are known carriers of the faulty CFTR gene, they can opt for amniocentesis or chorionic villus sampling (CVS) during pregnancy to determine if their baby will have cystic fibrosis. These tests analyse a sample of amniotic fluid or placental tissue for the CFTR gene mutation.

Additionally, couples planning a pregnancy can undergo pre-conception genetic screening to determine if they are carriers of the CFTR mutation. This allows them to understand the potential risks before conception and make informed decisions about family planning.

For women with cystic fibrosis, pregnancy can carry certain risks, especially if their lung function is severely compromised. The extra strain pregnancy places on the lungs and heart can lead to breathing difficulties, low oxygen levels, and a higher risk of complications like preterm birth or low birth weight.

However, with careful medical supervision, many women with CF can have successful pregnancies. Regular monitoring by a specialist team, adjustments to medications, and maintaining good nutritional status are essential for ensuring both maternal and foetal health.

Daily management of cystic fibrosis typically involves airway clearance techniques, such as chest physiotherapy, to help remove mucus from the lungs. Inhaled medications, like bronchodilators and mucolytics, are used to improve breathing and reduce mucus build-up. Antibiotics are frequently prescribed to prevent or treat lung infections.

Dietary management is also key. People with CF often require a high-calorie diet, along with pancreatic enzyme supplements, to help with digestion. Exercise is encouraged as it helps to keep the lungs clear and maintain overall health. Regular check-ups with a CF care team are essential for monitoring the condition and adjusting treatments as needed.

Yes, people with cystic fibrosis can work and attend school, though they may require accommodations due to their medical needs. Many people with CF lead full, active lives and pursue careers, though managing the condition requires regular treatments and medical appointments. It’s important to communicate with employers and schools about any specific needs or adjustments.

Maintaining a balance between treatment, rest, and work or study is key. Many with CF may experience periods of illness that require time off, but with supportive environments, people with cystic fibrosis can achieve their personal and professional goals.

In cases of severe lung disease caused by cystic fibrosis, a lung transplant may be considered as a treatment option. This is typically recommended for individuals whose lung function has significantly deteriorated, and other treatments are no longer effective. A transplant can improve quality of life and extend life expectancy, but it is not a cure for CF, as the underlying condition still affects other organs.

A lung transplant carries risks, including rejection and infection, and lifelong medications are required to suppress the immune system. However, for many people with end-stage CF lung disease, it can offer a second chance at life.

Cystic fibrosis can affect fertility, especially in men. Over 95% of men with CF are infertile due to a condition called congenital bilateral absence of the vas deferens (CBAVD) — where the tubes that carry sperm are either blocked or missing. This affects adults living with CF and is not something screening looks for in your baby. However, assisted reproductive technologies, such as IVF, can help many men with CF father biological children.

In women with CF, fertility is generally not as severely impacted, though thicker cervical mucus and respiratory health can make conception more challenging. With good health management and medical assistance, many women with CF can conceive and have successful pregnancies.

No, cystic fibrosis is not contagious. It is a genetic disorder that is passed down from parents to their children through mutations in the CFTR gene. Only individuals who inherit two faulty copies of the gene (one from each parent) will develop the condition.

However, people with CF are more susceptible to lung infections, which can be caused by bacteria that may be contagious. Therefore, those with CF often need to take extra precautions to avoid close contact with others who have CF or certain respiratory infections.

In the UK, newborn screening for cystic fibrosis is part of the routine heel-prick test performed on all babies within the first few days of life. This test checks for the presence of the faulty CFTR gene and other markers that may indicate CF. Early detection allows for immediate intervention and better management of the condition.

If the screening suggests cystic fibrosis, further tests, such as a sweat test, are conducted to confirm the diagnosis. Early diagnosis through newborn screening can significantly improve outcomes for children with cystic fibrosis.

Living with cystic fibrosis requires daily management, including airway clearance techniques, medications, and dietary supplements to maintain lung function and overall health. This can take considerable time and effort, but with a comprehensive care plan, many people with CF can live full, active lives.

Regular check-ups with a CF care team are essential for monitoring health, adjusting treatments, and preventing complications. Although CF can present challenges, advances in treatments and support networks have greatly improved the quality of life for people living with the condition.

Cystic fibrosis can lead to several complications, especially if not well-managed. The most common complications involve the lungs, where repeated infections can cause damage and lead to chronic conditions like bronchiectasis. Other complications include diabetes, due to damage to the pancreas, liver disease, and osteoporosis.

People with CF also face a higher risk of developing digestive issues, such as intestinal blockages and gallstones. Managing these complications requires a multidisciplinary approach, with treatments tailored to each individual’s specific health needs.